Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2020-09-24 Investor Presentation
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is titled 'Corporate Presentation September 2020' and is addressed as an intimation of an Analysts/Institutional Investor Meeting and Investor Presentation. It references Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which governs disclosures related to investor presentations. The content includes company profile, environmental facilities, business model, competitive edge, customer relationships, and future outlook, typical of an investor presentation. There is no detailed financial statement or audit report, nor is it a regulatory filing or announcement of voting results. The document is about a presentation shared with investors and analysts, not a full annual or quarterly report. Therefore, the appropriate classification is Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-09-24 English
Bodal Chemicals Limited has informed the Exchange about Analysts/Institutional Investor Meet and Corporate Presentation
Regulatory Filings
2020-09-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding newspaper advertisements for meetings convened by the National Company Law Tribunal (NCLT) concerning secured and unsecured creditors of two companies involved in a Scheme of Arrangement under Sections 230-232 of the Companies Act, 2013. The content includes regulatory references (SEBI Listing Obligations and Disclosure Requirements Regulations, 2015), dates of meetings, and details about the scheme approval process. It is an announcement of meetings and related procedural information rather than a financial report, audit, or management discussion. The document is not a full report but a regulatory announcement about the convening of creditor meetings for a corporate restructuring scheme. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-09-21 English
Bodal Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Regulatory Filings
2020-09-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a detailed notice convening a meeting of unsecured creditors of Trion Chemicals Private Limited pursuant to an order by the National Company Law Tribunal (NCLT). It includes references to the Scheme of Amalgamation between Trion Chemicals Private Limited and Bodal Chemicals Limited, explanatory statements under relevant sections of the Companies Act, and procedural details for the meeting and voting. The document is not a financial report, earnings release, or audit report, but rather a formal notice related to a legal and corporate restructuring process involving creditor approval. It is not a proxy solicitation or voting results announcement but a notice for a creditors' meeting convened by a tribunal order. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement related to corporate restructuring and creditor meetings under legal provisions, without being a direct financial report or other specific filing type.
2020-09-19 English
Updates
Regulatory Filings Classification · 95% confidence The document is a detailed notice convening a meeting of unsecured creditors of Bodal Chemicals Limited pursuant to an order by the National Company Law Tribunal (NCLT). It includes references to the Companies Act, 2013, and the Scheme of Amalgamation between Trion Chemicals Private Limited and Bodal Chemicals Limited. The document contains the agenda, explanatory statements, and annexures related to the scheme, including audited financial statements and valuation reports. The purpose is to seek approval from unsecured creditors for the scheme of amalgamation. This is not a full annual report, audit report, or earnings release, but a formal notice and explanatory statement related to a corporate restructuring meeting convened by a regulatory tribunal. It is not a proxy solicitation or voting results announcement but a notice of a meeting with detailed supporting documents. Therefore, the filing type best fitting this document is a Regulatory Filing (RNS), as it is a formal regulatory announcement and notice related to a corporate legal proceeding and meeting, without being a direct financial report or other specific category.
2020-09-19 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.